# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024, Regulation 13: Amendment to regulation 13


(1) Regulation 13 (supply of investigational medicinal products for the purpose of clinical trials) is amended as follows.
(2) In paragraph (1)(d), for “subject” substitute “participant”.
(3) In paragraph (2)(b)(ii)—
(a) in sub-paragraph (aa), for “Article 13 of the Directive” substitute “Article 62 of the EU Regulation”;
(b) in sub-paragraph (bb), for “Article 13(3) and (4) of the Directive” substitute “Article 62 of the EU Regulation”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348267167/regulation/13 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-13
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.